CD133 receptor mediated delivery of STAT3 inhibitor for simultaneous elimination of cancer cells and cancer stem cells in oral squamous cell carcinoma-Reference-Cited by-同舟云学术

CD133 receptor mediated delivery of STAT3 inhibitor for simultaneous elimination of cancer cells and cancer stem cells in oral squamous cell carcinoma

Published:2019-08 Issue: Volume:129 Page:109241
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Pindiprolu Sai Harshini,Pindiprolu Sai Kiran S.S.

Publisher

Elsevier BV

Subject

General Medicine

Reference20 articles.

1. Incidence trends for human papillomavirus-related and-unrelated oral squamous cell carcinomas in the United States;Chaturvedi;J Clin Oncol,2008

2. CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer;Liu;Oncogene,2013

3. Prospective identification of tumorigenic breast cancer cells;Al-Hajj;Proc Natl Acad Sci,2003

4. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma;Prince;Proc Natl Acad Sci,2007

5. Breast cancer stem cells;Velasco-Velázquez;Int J Biochem Cell Biol,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and Validation of a Prognostic Signature Derived from the Cancer Stem Cells for Oral Squamous Cell Carcinoma;International Journal of Molecular Sciences;2024-01-14

2. Engineered upconversion nanocarriers for synergistic breast cancer imaging and therapy: Current state of art;Journal of Controlled Release;2022-12

3. STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma;Cells;2022-10-05

4. Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets;Pharmaceutics;2022-01-12

5. A randomised controlled trial of effectiveness and safety of Niclosamide as add on therapy to the standard of care measures in COVID-19 management;Annals of Medicine and Surgery;2021-09